期刊文献+

^(131)I治疗甲亢前后甲状腺显像变化 被引量:4

Changes of thyroid nuclide imaging in patients of hyperthyroidism after ^(131)I therapy
下载PDF
导出
摘要 目的评价不同病因甲状腺功能亢进症(甲亢)的核素显像特征,观察131I治疗后甲状腺显像的变化。方法收集402例甲亢患者,于131I治疗前进行甲状腺显像,诊断甲亢病因;于131I治疗后6个月后再次进行甲状腺显像,比较治疗前后显像的变化。结果根据甲状腺显像结果,402例患者中,格雷夫斯病351例(351/402,87.31%),包括弥漫性甲状腺肿185例,结节性甲状腺肿166例;甲状腺自主性高功能腺瘤(TA)42例(42/402,10.45%);多结节性甲状腺肿伴甲亢(TMNG)9例(9/402,2.24%)。131I治疗后甲状腺显像:格雷夫斯病弥漫增生组织均匀缩小;TA热结节转变为冷结节,周围和对侧组织显影恢复;TMNG原多发小热结节多缩小或消失,原受抑甲状腺组织内出现新的多发小热结节。结论不同病因甲亢的甲状腺核素显像具有不同特征;131I治疗后甲状腺显像变化明显。 Objective To observe the manifestations of thyroid radionuclide imaging in hyperthyroidism induced by differ- ent causes and the changes of imaging after radioiodine 131(131I) treatment. Method Totally 402 patients with hyperthy- roidism underwent thyroid radionuclide imaging to diagnose the cause of disease before 131I therapy. Changes of thyroid ra- dionuclide imaging were observed 6 months after 131I therapy and was compared with those before therapy. Results Ac cording to the thyroid radionuclide imaging, there were 351 cases (351/402, 87.31% ) of Graves disease, including 185 dif fuse goiter and 166 nodular goiter, 42 cases (42/402, 10.45%) of solitary toxic adenoma (TA) and 9 cases (9/402, 2.24%) of toxic muhinodular goitre (TMNG). After 131I therapy, diffuse hyperplasia of thyroid tissue lessened in Graves disease, the hot nodule was converted into cold nodule and the developments of surrounding, while contralateral tissues were recovered in TA, multiple hot nodules on original location lessened or disappeared and occurred in former inhibited tis- sues in TMNG. Conclusion Hyperthyroidism induced by different causes shows different characteristics in thyroid nuclide imaging. There are significant changes of imaging before and after treatment with 131I.
出处 《中国医学影像技术》 CSCD 北大核心 2013年第9期1442-1445,共4页 Chinese Journal of Medical Imaging Technology
关键词 甲状腺功能亢进症 甲状腺 放射性核素显像 放射性碘 Hyperthyroidism Thyroid gland Radionuclide imaging Radio-iodine
  • 相关文献

参考文献13

  • 1蒋宁一,匡安仁,谭建,陆汉魁,林岩松,丁虹,张永学.131I治疗Graves甲亢专家共识(2010年)[J].中华核医学杂志,2010,30(5):346-351. 被引量:118
  • 2Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 2011,17(3):456-520.
  • 3中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南-甲状腺功能亢进症[J].中华内科杂志,2007,46:876-882.
  • 4陈贵兵,林金海,黄劲雄,何小江,俞浩,许威毅,肖小兰,王璘.^(99m)Tc-Octreotide显像与高频超声在甲状腺实性冷结节定性诊断中的比较[J].中国医学影像技术,2013,29(3):354-357. 被引量:4
  • 5李俊红,韦智晓,李亚范.甲状腺显像疏/甲比预测^(131)I治疗Graves病后甲状腺功能减退症[J].中国医学影像技术,2011,27(7):1374-1377. 被引量:3
  • 6郭满涛,李亚明,尹雅芙.甲状腺显像评估甲状腺体积的方法及影响因素[J].中国医学影像技术,2011,27(6):1295-1298. 被引量:7
  • 7Intenzo CM, Dam HQ, Manzone TA, et al. Imaging of the thyroid in benign and malignant disease. Semin Nucl Med, 2012,42(1):49-61.
  • 8Szumowski P, Rogowski F, Abdelrazek S, et al. Iodine isotope 131I therapy for toxic nodular goitre: Treatment efficacy parameters. Nucl Med Rev Cent East Eur, 2012,15(1):7-13.
  • 9Al-Sharif AA, Abujbara MA, Chiacchio S, et al. Contribution of radioiodine uptake measurement and thyroid scintigraphy to the differential diagnosis of thyrotoxicosis. Hell J Nucl Med, 2010,13(2):132-137.
  • 10Intenzo CM, dePapp AE, Jabbour S, et al. Scintigraphic manifestations of thyrotoxicosis. Radiographics, 2003,23(4):857-869.

二级参考文献61

共引文献139

同被引文献18

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部